{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T11:14:27Z","timestamp":1782213267688,"version":"3.54.5"},"reference-count":54,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":3282,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.fertnstert.2013.03.001","type":"journal-article","created":{"date-parts":[[2013,3,30]],"date-time":"2013-03-30T06:45:19Z","timestamp":1364625919000},"page":"1825-1830","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":94,"title":["Why we may abandon basal follicle-stimulating hormone testing: a sea change in determining ovarian reserve using antim\u00fcllerian hormone"],"prefix":"10.1016","volume":"99","author":[{"given":"James P.","family":"Toner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Seifer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2013.03.001_bib1","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0015-0282(16)46814-7","article-title":"Human menopausal gonadotropin\/human chorionic gonadotropin follicular maturation of oocyte aspiration: phase I, 1981","volume":"39","author":"Garcia","year":"1983","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2013.03.001_bib2","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0015-0282(16)46815-9","article-title":"Human menopausal gonadotropin\/human chorionic gonadotropin follicular maturation of oocyte aspiration: phase II, 1981","volume":"39","author":"Garcia","year":"1983","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2013.03.001_bib3","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0015-0282(16)60077-8","article-title":"The value of basal and\/or stimulated serum gonadotropin levels in prediction of stimulation response and in\u00a0vitro fertilization outcome","volume":"50","author":"Muasher","year":"1988","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2013.03.001_bib4","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/S0015-0282(16)54249-6","article-title":"Basal follicle-stimulating hormone level is a better predictor of in\u00a0vitro fertilization performance than age","volume":"55","author":"Toner","year":"1991","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2013.03.001_bib5","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0950-3552(05)80131-2","article-title":"The significance of elevated FSH for reproductive function","volume":"7","author":"Toner","year":"1993","journal-title":"Baillieres Clin Obstet Gynaecol"},{"key":"10.1016\/j.fertnstert.2013.03.001_bib6","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0140-6736(87)92439-1","article-title":"Prognostic assessment of female fecundity","volume":"19","author":"Navot","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2013.03.001_bib7","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1093\/oxfordjournals.humrep.a138760","article-title":"Exogenous follicle stimulating hormone ovarian reserve test (EFORT): a simple and reliable screening test for detecting \u2018poor responders\u2019 in in-vitro fertilization","volume":"9","author":"Fanchin","year":"1994","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2013.03.001_bib8","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0015-0282(16)54604-4","article-title":"The gonadotropin-releasing hormone agonist stimulation test\u2014a sensitive predictor of performance in the flare-up in\u00a0vitro fertilization cycle","volume":"56","author":"Winslow","year":"1991","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2013.03.001_bib9","first-page":"49","article-title":"The human granulosa cell model-lessons gleaned from assisted reproductive technologies","volume":"3","author":"Seifer","year":"1993","journal-title":"Assist Reprod Rev"},{"key":"10.1016\/j.fertnstert.2013.03.001_bib10","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/0002-9378(93)90430-Q","article-title":"Proliferative index of human luteinized granulosa cells varies as a function of ovarian reserve","volume":"169","author":"Seifer","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2013.03.001_bib11","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0015-0282(16)58573-2","article-title":"Apoptosis as a function of ovarian reserve in women undergoing in\u00a0vitro fertilization","volume":"66","author":"Seifer","year":"1996","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2013.03.001_bib12","series-title":"Perimenopause","article-title":"Granulosa cell competence with aging","author":"Seifer","year":"1997"},{"key":"10.1016\/j.fertnstert.2013.03.001_bib13","first-page":"736","article-title":"Differential secretion of dimeric inhibin in cultured luteinized granulosa cells as a function of ovarian reserve","volume":"81","author":"Seifer","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2013.03.001_bib14","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0015-0282(97)81865-1","article-title":"Day 3 serum inhibin-B is predictive of assisted reproductive technologies outcome","volume":"67","author":"Seifer","year":"1997","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2013.03.001_bib15","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0015-0282(99)00193-4","article-title":"Women with declining ovarian reserve may demonstrate a decrease in day 3 serum inhibin-B before a rise in day 3 FSH","volume":"72","author":"Seifer","year":"1999","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2013.03.001_bib16","first-page":"711","article-title":"Gonadotropin releasing hormone agonist induced differences in granulosa cell cycle kinetics are associated with alterations in follicular fluid m\u00fcllerian inhibiting substance and androgen content","volume":"76","author":"Seifer","year":"1993","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2013.03.001_bib17","doi-asserted-by":"crossref","first-page":"5789","DOI":"10.1210\/endo.140.12.7204","article-title":"Control of primordial follicle recruitment by anti-M\u00fcllerian hormone in the mouse ovary","volume":"140","author":"Durlinger","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.fertnstert.2013.03.001_bib18","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0015-0282(01)03201-0","article-title":"Early follicular serum m\u00fcllerian- inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles","volume":"77","author":"Seifer","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2013.03.001_bib19","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.fertnstert.2012.11.051","article-title":"Biomarkers of ovarian response: current and future applications","volume":"99","author":"Nelson","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2013.03.001_bib20","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.1210\/jc.2006-0331","article-title":"Anti-M\u00fcllerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation","volume":"91","author":"Hehenkamp","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2013.03.001_bib21","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/humrep\/dep366","article-title":"Comparison of inter- and intra-cycle variability of anti-M\u00fcllerian hormone and antral follicle counts","volume":"25","author":"van Disseldorp","year":"2010","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2013.03.001_bib22","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/humrep\/deh688","article-title":"High reproducibility of serum anti-m\u00fcllerian hormone measurements suggests a multi-staged follicular secretion and strengthens its role in the assessment of ovarian follicular status","volume":"20","author":"Fanchin","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2013.03.001_bib23","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.fertnstert.2007.02.014","article-title":"M\u00fcllerian inhibiting substance is an ovarian\u00a0growth factor of emerging clinical significance","volume":"88","author":"Seifer","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2013.03.001_bib24","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1093\/humrep\/dem204","article-title":"Serum anti-m\u00fcllerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles\u2014implications for individualization of therapy","volume":"22","author":"Nelson","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2013.03.001_bib25","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.fertnstert.2010.10.011","article-title":"Age-specific antim\u00fcllerian hormone values for 17,120 women presenting to fertility centers within the United States","volume":"95","author":"Seifer","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2013.03.001_bib26","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.rbmo.2010.05.009","article-title":"Normal serum concentrations of anti-m\u00fcllerian hormone in women with regular menstrual cycles","volume":"21","author":"La Marca","year":"2010","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2013.03.001_bib27","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1111\/j.1600-0412.2012.01448.x","article-title":"Age-related distributions of anti-m\u00fcllerian hormone level and anti-m\u00fcllerian hormone models","volume":"91","author":"Lee","year":"2012","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.fertnstert.2013.03.001_bib28","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ejogrb.2012.04.013","article-title":"Normal serum anti-m\u00fcllerian hormone levels in the general female population and the relationship with reproductive history","volume":"163","author":"La Marca","year":"2012","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.fertnstert.2013.03.001_bib29","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.rbmo.2010.12.002","article-title":"Utility of age-specific serum anti-m\u00fcllerian hormone concentrations","volume":"22","author":"Barad","year":"2011","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2013.03.001_bib30","doi-asserted-by":"crossref","first-page":"4650","DOI":"10.1210\/jc.2012-1440","article-title":"Serum anti-m\u00fcllerian hormone levels in healthy females: a nomogram ranging from infancy to adulthood","volume":"97","author":"Lie Fong","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2013.03.001_bib31","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1016\/j.fertnstert.2011.02.057","article-title":"Age-related normograms of serum antim\u00fcllerian hormone levels in a population of infertile women: a multicenter study","volume":"95","author":"Almog","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2013.03.001_bib32","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.fertnstert.2008.08.127","article-title":"Circulating basal anti-m\u00fcllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in\u00a0vitro fertilization","volume":"92","author":"Nardo","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2013.03.001_bib33","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/humupd\/dmp036","article-title":"Anti-m\u00fcllerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART)","volume":"16","author":"La Marca","year":"2010","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2013.03.001_bib34","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jim.2010.08.011","article-title":"Development of a second-generation anti-m\u00fcllerian hormone (AMH) ELISA","volume":"362","author":"Kumar","year":"2010","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.fertnstert.2013.03.001_bib35","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1210\/jc.2012-3176","article-title":"Modeling age at menopause using serum concentration of anti-m\u00fcllerian hormone","volume":"98","author":"Tehrani","year":"2013","journal-title":"J Clin Endocrin Metab"},{"key":"10.1016\/j.fertnstert.2013.03.001_bib36","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.fertnstert.2005.09.019","article-title":"Early follicular antim\u00fcllerian hormone as an indicator of ovarian reserve","volume":"85","author":"Ficicioglu","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2013.03.001_bib37","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1111\/j.1471-0528.2005.00670.x","article-title":"Antral follicle count, anti-m\u00fcllerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology?","volume":"112","author":"Muttukrishna","year":"2005","journal-title":"Br J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2013.03.001_bib38","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1093\/humrep\/den108","article-title":"Relevance of anti-m\u00fcllerian hormone measurement in a routine IVF program","volume":"23","author":"Gnoth","year":"2008","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2013.03.001_bib39","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/humrep\/deh718","article-title":"Basal and stimulation day 5 anti-m\u00fcllerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted\u00a0reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist\u2013gonadotropin treatment","volume":"20","author":"Penarrubia","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2013.03.001_bib40","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1210\/jc.2010-2776","article-title":"Anti-m\u00fcllerian hormone predicts menopause: a long-term follow-up study in normoovulatory women","volume":"96","author":"Broer","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2013.03.001_bib41","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1093\/humrep\/der182","article-title":"Anti-m\u00fcllerian hormone-tailored stimulation protocols improve outcomes whilst reducing adverse effects and costs of IVF","volume":"26","author":"Yates","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2013.03.001_bib42","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1093\/humrep\/den480","article-title":"Anti-m\u00fcllerian hormone-based approach to controlled ovarian stimulation for assisted conception","volume":"24","author":"Nelson","year":"2009","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2013.03.001_bib43","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/j.1471-0528.2012.03412.x","article-title":"Development of a nomogram based on markers of ovarian reserve for the individualisation of the follicle-stimulating hormone starting dose in in\u00a0vitro fertilisation cycles","volume":"119","author":"La Marca","year":"2012","journal-title":"BJOG"},{"key":"10.1016\/j.fertnstert.2013.03.001_bib44","article-title":"Anti-m\u00fcllerian hormone (AMH) is an independent predictor of twin versus singleton pregnancy in fresh ART cycles","author":"Tal","year":"2012","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2013.03.001_bib45","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/AOG.0b013e318278eeda","article-title":"Association of abnormal ovarian reserve parameters with\u00a0a higher incidence of aneuploid blastocysts","volume":"121","author":"Katz-Jaffe","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2013.03.001_bib46","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1016\/j.fertnstert.2011.03.071","article-title":"Random anti-m\u00fcllerian hormone (AMH) is a predictor of ovarian response in women with elevated baseline early follicular FSH levels","volume":"95","author":"Buyuk","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2013.03.001_bib47","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.fertnstert.2012.06.006","article-title":"Discordance between anti-m\u00fcllerian hormone (AMH) and follicle stimulating hormone (FSH) in menstrual cycle day 2-4 serum from 5,354 women in US fertility centers","volume":"98","author":"Leader","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2013.03.001_bib48","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/humrep\/deg043","article-title":"Serum anti-m\u00fcllerian hormone dynamics during controlled ovarian hyperstimulation","volume":"18","author":"Fanchin","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2013.03.001_bib49","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.rbmo.2010.04.006","article-title":"Improvement in diminished ovarian reserve after dehydroepiandrosterone supplementation","volume":"21","author":"Gleicher","year":"2010","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2013.03.001_bib50","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1210\/jc.2012-3071","article-title":"A randomized double-blinded placebo-controlled trial on the effect of dehydroepiandrosterone for 16 weeks on ovarian response markers in women with primary ovarian insufficiency","volume":"98","author":"Yeung","year":"2013","journal-title":"Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2013.03.001_bib51","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1007\/s00404-011-2169-2","article-title":"Coenzyme Q10 content in follicular fluid and its relationship with oocyte\u00a0fertilization and embryo grading","volume":"285","author":"Turi","year":"2012","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.fertnstert.2013.03.001_bib52","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.fertnstert.2012.03.029","article-title":"Circulating vitamin D correlates with serum antim\u00fcllerian hormone levels in late-reproductive-aged women: women's interagency HIV Study","volume":"98","author":"Merhi","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2013.03.001_bib53","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1210\/jc.2012-1213","article-title":"The level of serum anti-m\u00fcllerian hormone correlates with vitamin D status\u00a0in men and women but not in boys","volume":"97","author":"Dennis","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2013.03.001_bib54","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1093\/humrep\/dep210","article-title":"ESHRE special\u00a0interest group for reproductive endocrinology\u2013AMH round table. anti-m\u00fcllerian hormone (AMH): what do we still need to know?","volume":"24","author":"La Marca","year":"2009","journal-title":"Hum Reprod"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028213003944?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028213003944?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T16:16:39Z","timestamp":1775232999000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028213003944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":54,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0015028213003944"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2013.03.001","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Why we may abandon basal follicle-stimulating hormone testing: a sea change in determining ovarian reserve using antim\u00fcllerian hormone","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2013.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}